I
IFRX
Inflarx
2.610
+0.140+5.67%After Hours: 2.560 -0.050 -1.92%19:49 05/22 EDT
OPEN/PREV CLOSE2.520/2.470
TODAY RANGE2.510-2.700
VOL1.51M
MARKET CAP384.43M
52 WEEK RANGE0.7113-2.949
AVG VOL (3M)1.54M
% TURNOVER1.02%
TURNOVER--
P/E (TTM)-3.6326
% RANGE7.69%
EPS(TTM)-0.7185
P/E(FORWARD)-7.3750
P/B4.432
BVPS0.5889
DIVIDEND--
P/S5,220.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP373.15M
SHARES OUTSTANDING147.29M
NEXT EARNINGS08/05-08/10
FREE FLOAT142.97M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·05/13 18:03
InflaRx Raised to Strong Buy From Outperform by Raymond James
Dow Jones·05/13 18:03
InflaRx Price Target Raised to $9.00/Share From $7.00 by Raymond James
Benzinga·05/13 17:53
Raymond James Upgrades InflaRx to Strong Buy, Raises Price Target to $9
TipRanks·05/13 12:32
InflaRx upgraded to Strong Buy from Outperform at Raymond James
TipRanks·05/11 18:30
InflaRx price target raised to $8 from $6 at H.C. Wainwright
Dow Jones·05/11 17:42
InflaRx Price Target Raised to $8.00/Share From $6.00 by HC Wainwright & Co.
Dow Jones·05/11 17:42
InflaRx Is Maintained at Buy by HC Wainwright & Co.
Benzinga·05/11 17:36
HC Wainwright & Co. Maintains Buy on InflaRx, Raises Price Target to $8
Dow Jones·05/11 13:57
InflaRx Price Target Raised to $4.00/Share From $2.00 by Cantor Fitzgerald
Dow Jones·05/11 13:57
InflaRx Is Maintained at Overweight by Cantor Fitzgerald
Benzinga·05/11 13:47
Cantor Fitzgerald Maintains Overweight on InflaRx, Raises Price Target to $4
TipRanks·05/11 12:31
Cantor Fitzgerald Remains a Buy on InflaRx (IFRX)
TipRanks·05/11 11:46
Guggenheim Sticks to Its Buy Rating for InflaRx (IFRX)
Benzinga·05/08 21:06
12 Health Care Stocks Moving In Friday's After-Market Session